Myriad Genetics
MYGN
#6699
Rank
S$0.85 B
Marketcap
S$9.19
Share price
-3.27%
Change (1 day)
-58.03%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.46 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are S$0.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.44 B-7.5%
2023-12-31S$0.47 B14.38%
2022-12-31S$0.41 B-12.08%
2021-12-31S$0.47 B
2020-06-30S$0.67 B5.84%
2019-06-30S$0.64 B124.64%
2018-06-30S$0.28 B-53.02%
2017-06-30S$0.60 B240.29%
2016-06-30S$0.17 B27.16%
2015-06-30S$0.14 B7.35%
2014-06-30S$0.13 B36.86%
2013-06-30S$95.46 M37.04%
2012-06-30S$69.65 M28.9%
2011-06-30S$54.03 M7.31%
2010-06-30S$50.35 M8.37%
2009-06-30S$46.46 M-53.66%
2008-06-30S$0.10 B85.85%
2007-06-30S$53.95 M26.4%
2006-06-30S$42.68 M8.28%
2005-06-30S$39.42 M52.52%
2004-06-30S$25.85 M-23.86%
2003-06-30S$33.95 M-32.65%
2002-06-30S$50.4 M-15.12%
2001-06-30S$59.38 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
S$3.83 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
S$4.40 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
S$28.27 M-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.02 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$42.67 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA